Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gallas

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Urology|November 1, 1975
The external shunt in the treatment of idiopathic priapismH W Cate, P Gallas, P Thé
The Veterinary Record|August 16, 2002
Risk-based evaluation of postmortem inspection procedures for pigs in AustraliaD R Hamilton, P Gallas, L Lyall, et al.
Annals of Hematology|June 15, 2016
Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experienceJ Bourcier, T Gastinne, C Leux, et al.
Annals of Hematology|April 5, 2017
Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomasB Tessoulin, P Thomare, E Delande, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Urology|November 1, 1975
The external shunt in the treatment of idiopathic priapismH W Cate, P Gallas, P Thé
The Veterinary Record|August 16, 2002
Risk-based evaluation of postmortem inspection procedures for pigs in AustraliaD R Hamilton, P Gallas, L Lyall, et al.
Annals of Hematology|June 15, 2016
Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experienceJ Bourcier, T Gastinne, C Leux, et al.
Annals of Hematology|April 5, 2017
Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomasB Tessoulin, P Thomare, E Delande, et al.
Pageof 1